At a glance
CDC works with partners in Vietnam to strengthen the country's public health and clinical systems. CDC delivers quality HIV testing and treatment services and responds to emerging public health threats.
Background
The U.S. Centers for Disease Control and Prevention (CDC) established its office in Vietnam in 1998. Since 2003, CDC has been a principal agency for HIV programs under the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR). Partnering with the Ministry of Health, CDC Vietnam supports transitioning HIV and TB services to domestic financing and program responsibility. This transition prioritizes continuity, quality of patient services, and sustainability by advancing scientific innovations and equity for people at higher risk.
CDC also supports Vietnam’s National Tuberculosis (TB) Program (NTP). CDC provides direct technical assistance to strengthen efforts to find, cure, and prevent TB, HIV-associated TB, and multidrug-resistant TB. Efforts include building capacity to operationalize new and existing TB control tools and using evidence for data-driven TB control and prevention.
Download CDC Vietnam's Fact Sheet
HIV and TB data
HIV/AIDS
Estimated HIV Prevalence (Ages 15-49)
Estimated AIDS Deaths (Age≥15)
Estimated Orphans Due to AIDS
Reported Number Receiving Antiretroviral Therapy (Age≥15)
Tuberculosis (TB)
Estimated TB Incidence
TB Patients with Known HIV-Status who are HIV-Positive
TB Treatment Success Rate
Key activities and accomplishments
CDC Vietnam supports the national HIV response through innovations, including the scale-up of robust HIV public health surveillance. Other innovations include the introduction of person-centered care and integrated service delivery models for HIV prevention and treatment. Additionally, CDC advanced stigma and discrimination reduction activities and strengthened program quality improvement by provincial and local health authorities. CDC is a lead partner in evaluating and improving TB case-finding, optimizing TB treatment for latent and active cases. Other key activities include infection control, surveillance, and building laboratory capacity.
HIV testing, treatment, and prevention
CDC leads the national implementation of HIV recency testing as part of a provincially-led public health cluster response. This testing model rapidly mobilizes resources and technical assistance to signals of active HIV transmission.
CDC-supported provinces continue successfully transitioning people living with HIV (PLHIV) to the Government of Vietnam’s (GVN) social health insurance (SHI). 93 percent of PLHIV receive antiretroviral therapy (ART) through SHI. CDC sites were the first to implement multi-month dispensing of ART through SHI. CDC sites were also first to strengthen treatment continuity and provide an integrated model for screening and treating other chronic diseases. At CDC/PEPFAR supported sites, 99 percent of patients with viral load testing in the past year are virally suppressed (<1,000 copies/mL).
CDC and partners emphasize biomedical prevention through an innovative status-neutral approach for HIV treatment and prevention services. This partnership includes the GVN, the Vietnam Network of People Living with HIV (VNP+), and community-based and international organizations. This work builds upon on the internationally recognized undetectable equals untransmittable (K=K in Vietnam) campaign.
With CDC support, over 19,000 clients have started pre-exposure prophylaxis (PrEP) in 2021 and 2022. CDC is supporting GVN to further scale up PrEP through diversified service delivery models, long-acting regimens and best practices for adherence.
Establishing HIV public health surveillance
CDC supports the GVN to establish a national HIV case surveillance system to longitudinally follow PLHIV from diagnosis to death. This includes reporting sentinel events, to inform epidemiologic trends for program planning. Reporting also helps identify gaps in program performance to improve patient outcomes for PLHIV.
Person-centered innovations
CDC drives innovative approaches, such as community advisory boards and scorecards. These innovations include the community’s voice in developing differentiated HIV programming that fits key populations’ needs.
Person-centered program innovations have been piloted and scaled in academic, public, and private sites. These include multi-month dispensing, same-day treatment initiation, and diversified service delivery.
Integrated service delivery models
CDC supports integration of HIV with other health services to promote quality of life and reduce morbidity and mortality in PLHIV. Health services integration include mental health, non-communicable diseases, hepatitis, sexually transmitted infections, and cervical cancer screening.
Tuberculosis (TB)
CDC supports GVN in implementing and establishing the national policy of HIV testing and counseling among TB patients. CDC also takes the lead on TB innovations with GVN. One innovation uses the 2X (X-ray & GeneXpert) algorithm for intensified case-finding and demonstrating new screening (C-reactive protein point-of-care test [CRP POCT]).
Other TB innovations include diagnostics (lateral flow urine lipoarabinomannan [LF-LAM] assay) and short course TB preventive treatment (3HP) in PLHIV.
CDC supports GVN in independently producing GeneXpert proficiency testing panels. Additionally, CDC supports GVN in leading external quality assessments for GeneXpert laboratory sites in Vietnam and the region. CDC also supports resilience in HIV services and systems to respond effectively to non-HIV outbreaks affecting PLHIV, including COVID-19 and Mpox.
Resources
Support for CDC's global HIV and TB efforts.
Our success is built on the backbone of science and strong partnerships.